Cortechs.ai | 3.0 release brings change visualization to NeuroQuant<sup>®</sup>

3.0 release brings change visualization to NeuroQuant®

With the new release of NeuroQuant® 3.0, users will now have access to the change visualization output, previously available only through LesionQuant. Now compare two 3D T1 scans to detect and highlight the volumetric change within an easy to interpret heat map overlay. Users will see voxel-specific changes between the two scans highlighted in a color-coded heat map returned to the PACS system as a DICOM volume. The detailed 3D overlay provides high-resolution images to inform physicians of very subtle changes such as ventricle expansion, tissue atrophy and swelling that would otherwise be undetected by the human eye.

 

Sagital NQChange    NQChange Visualization AxialNQChange Visualization

 

The change analysis also highlights areas of significant volume changes that may be a result of medication, injury, or disease progression. This output fully integrates into the existing workflow and provides a DICOM overlay of co-registered and aligned images between time points.

To generate a change visualization output for NeuroQuant® or LesionQuant, the raw data from the baseline scan must be available in the NeuroQuant® database. If the baseline data is available, NeuroQuant® and LesionQuant will automatically generate change visualization outputs if the scan protocols are comparable. If baseline data is not available, the user will upload the baseline scan 3D T1 (and FLAIR for LesionQuant) for analysis, then upload the current time point data.

NeuroQuant® 2.3 will continue to be available to all customers however all new features will only be available with NeuroQuant® 3.0. Learn more about the new and improved features NeuroQuant® 3.0 can bring to you and your patients.

Ready to upgrade to 3.0? Click here to request migration to NeuroQuant® 3.0.

 

More Resources

03/04/2026

Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies

NeuroQuant® Lesion Surveillance will be integrated into the Siemens Healthineers Digital Marketplace to advance quantitative brain imaging worldwide.

02/25/2026

Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea

MFDS approves NeuroQuant® V5 in South Korea, expanding AI-driven volumetric neuroimaging and clinical decision support.

02/24/2026

Financial Conflict Of Interest Policy Applicable To NIH Awards

02/20/2026

NeuroQuant® PET: FDA 510(k)-Pending Advancement in Molecular Dementia Imaging

FDA 510(k)-Pending NeuroQuant® PET delivers automated, standardized quantification for amyloid, tau, and FDG imaging in dementia care.

02/19/2026

How Cortechs.ai Protects ePHI: HIPAA‑Aligned Controls—and Beyond

Cortechs.ai’s HIPAA-aligned, defense-in-depth security safeguards ePHI across AI workflows—exceeding baseline compliance standards.

02/11/2026

NeuroQuant Normative Database: Advancing Age‑ and Sex‑Specific Brain Volumetry

Learn how the latest updates to the NeuroQuant normative database white paper strengthen age- and sex-specific brain volumetry and enhance clinical confidence.
Scroll to Top